RankAlpha logo
Back to Rankings

ENGN

enGene TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Mature LEGEND durability could support the planned regulatory path. enGene reported $266.3 million in cash, cash equivalents and marketable securities at July 31, 2026, providing resources for development and filing preparation.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
FDA feedback may require more evidence or delay the planned BLA submission. [#SEC-8K-2026-09-08]
Momentum
46
Value
57
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.50 · Bull $3.20 · Bear $0.50Analysis 2026-10-20; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-20 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $3.50
Why
Momentum46 · Δ7d -
Value57 · Δ7d -0.3
Sentiment47 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta -0.3.

Contradictions & invalidation

  • • FDA feedback may require more evidence or delay the planned BLA submission. [#SEC-8K-2026-09-08]
  • • Mature complete-response and 12-month durability results may fall short of the interim signal. [#SEC-8K-2026-09-08]
  • • Interim response may weaken as data mature, FDA feedback may require more evidence, and filing timing could slip.

Catalyst clock

2026-12-31

LEGEND pivotal-cohort response and durability update

Lead driver: Value · See fundamentals
Momentum
46
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
57
47% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.8
Sentiment
47
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 46.2 / Value 56.6 / Sentiment 47.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-20. Scenario method

B+
Bull case
20%
Probability
Target price
$3.20
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
Most likely
B
Base case
40%
Probability
Target price
$1.50
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
B-
Bear case
40%
Probability
Target price
$0.50
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$104.55M
Beta
-0.28
Shares Out
67.02M
P/E (TTM) · Derived
-0.7
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.83
Rev YoY
-
EPS YoY
-14.3%
Gross Margin
-
Op Margin
-
Net Debt
-$162.02M
Current Ratio
12.57
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data